VAC14 抗体 (C-Term)
Our Local Distributor
北京 101111
Quick Overview for VAC14 抗体 (C-Term) (ABIN6244120)
抗原
See all VAC14 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 769-802, C-Term
-
预测反应
- B
-
纯化方法
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
免疫原
- This VAC14 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 769-802 amino acids from the C-terminal region of human VAC14.
-
亚型
- Ig Fraction
-
-
-
-
应用备注
- WB: 1:1000
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
有效期
- 6 months
-
-
- VAC14 (Vac14 Homolog (VAC14))
-
别名
- VAC14
-
背景
- The PI(3,5)P2 regulatory complex regulates both the synthesis and turnover of phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2). Acts as a positive activator of PIKfyve kinase activity. Also required to maintain normal levels of phosphatidylinositol 3-phosphate (PtdIns(3)P) and phosphatidylinositol 5-phosphate (PtdIns(5)P). Plays a role in the biogenesis of endosome carrier vesicles (ECV) / multivesicular bodies (MVB) transport intermediates from early endosomes.
-
分子量
- 87973
-
UniProt
- Q08AM6
-
途径
- Inositol Metabolic Process
抗原
-